Sutro Biopharma
STRO
#8443
Rank
NZ$0.27 B
Marketcap
$3.31
Share price
-0.53%
Change (1 day)
-50.49%
Change (1 year)

Sutro Biopharma (STRO) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.68 Billion

According to Sutro Biopharma's latest financial reports the company has NZ$0.68 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sutro Biopharma - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31NZ$0.52 B81.73%
2021-12-31NZ$0.28 B-43.2%
2020-12-31NZ$0.51 B191.54%
2019-12-31NZ$0.17 B-42.59%
2018-12-31NZ$0.30 B883.25%
2017-12-31NZ$31 M-54.81%
2016-12-31NZ$68.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$29.02 M-95.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.71 B 4.67%๐Ÿ‡บ๐Ÿ‡ธ USA